Home
/
NowPatient Blog
/
What is zepbound vs mounjaro?

What is zepbound vs mounjaro?

Navin Khosla NowPatientGreen tick
Created on 16 Jul 2024
Updated on 16 Jul 2024

In the battle against obesity and being overweight, new weight loss drugs like Zepbound, Mounjaro, Wegovy, and Ozempic are changing the landscape of treatment options. These medications offer hope for individuals struggling with excess weight and related conditions. But how do these drugs compare in terms of efficacy, cost, and overall effectiveness? Zepbound has been FDA-approved (Food and Drug Administration) in the United States, but only Mounjaro has UK MHRA (Medicines and Healthcare products Regulatory Agency) approval, so you’re only likely to find Mounjaro for sale in the UK for now.

In this comprehensive article, we will delve into the details of brand name drugs Zepbound and Mounjaro, manufactured by Eli Lilly. exploring their mechanisms of action, clinical trials, side effects, and more. By the end, you’ll have a clear understanding of these groundbreaking weight loss drugs and how they stack up against each other.

Mechanism of action

Understanding how weight loss drugs work is crucial to assess their potential effectiveness. Zepbound and Mounjaro both target specific mechanisms in the body to promote weight loss and contain the same active ingredient called tirzepatide. Zepbound activates receptors of hormones secreted from the intestine, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which reduce appetite and food intake. On the other hand, Mounjaro works by improving blood sugar levels in individuals with type 2 diabetes, which can indirectly lead to weight loss. By targeting these different pathways, both drugs aim to help individuals achieve their weight loss goals.

Clinical trials and efficacy

Clinical trials play a crucial role in determining the efficacy of weight loss drugs. Zepbound and Mounjaro have undergone rigorous testing to evaluate their effectiveness in promoting weight loss. In studies involving obese or overweight patients, both drugs demonstrated significant reductions in body weight compared to placebo. Additionally, a higher proportion of patients treated with Zepbound and Mounjaro achieved at least a 5% weight reduction, a clinically significant milestone. These promising results highlight the potential of these drugs in combating obesity.

Side effects and safety

As with any medication, it’s essential to consider the potential side effects and safety profile of Zepbound and Mounjaro. Common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, and abdominal discomfort. It may also cause injection site reactions, fatigue, allergic reactions, burping, hair loss, and gastroesophageal reflux disease. On the other hand, Mounjaro may lead to symptoms such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath, which may be signs of thyroid cancer. Both drugs have specific contraindications and precautions, and it’s crucial to consult with a healthcare provider before starting treatment.

Dosage and administration

Proper dosage and administration are essential for the effective use of weight loss drugs. Zepbound is administered through subcutaneous injections once a week. The dosage must be titrated over several weeks to achieve the target dose of 5 mg, 10 mg, or 15 mg once weekly. The maximum recommended dosage is 15 mg once weekly. Similarly, Mounjaro is also administered through subcutaneous injections, typically once weekly, but the specific dosage and administration guidelines may vary. It’s crucial to follow the prescribed regimen and consult with a healthcare provider for individualized guidance.

Cost and affordability

The cost of medication is an important consideration for many individuals who seek to lose weight. The affordability of Zepbound and Mounjaro may vary depending on factors such as insurance coverage, discounts, and patient assistance programs. It’s advisable to check with insurance providers and explore available resources to determine the cost of these drugs. Additionally, discussing options with healthcare providers and exploring alternative weight loss treatments may help individuals find the most cost-effective solution that fits their budget.

Comparison of Zepbound and Mounjaro

Now that we’ve explored the individual details of Zepbound and Mounjaro, let’s compare these two weight loss drugs side by side. While both medications aim to assist with weight loss, they have distinct mechanisms of action, clinical trial results, safety profiles, and costs.

It is important to note that Zepbound is indicated for chronic weight management in adult patients with obesity with a BMI (body mass index) of 30 +, or who are overweight with a BMI of 27+ with weight-related medical health conditions. Weight-related conditions may include high blood pressure (hypertension) or high cholesterol. On the other hand, Mounjaro is a diabetes drug indicated to be used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

Understanding these differences can help individuals make informed decisions about which drug may be more suitable for their specific needs. It’s crucial to consider factors such as existing medical conditions, medication interactions, and personal preferences when choosing between Zepbound and Mounjaro.

Zepbound: A closer look

Clinical trials and results

Zepbound has undergone extensive clinical trials to evaluate its efficacy in promoting weight loss. In these trials, patients treated with Zepbound at different dose levels experienced statistically significant reductions in body weight compared to those who received a placebo. Furthermore, a higher proportion of patients treated with Zepbound achieved at least a 5% weight reduction, a significant milestone in weight management. These positive results indicate the potential of Zepbound as an effective weight-loss medication.

Mechanism of action

Zepbound activates receptors of hormones secreted from the intestine, such as GLP-1 and GIP. By stimulating these receptors, Zepbound reduces appetite and food intake, leading to weight loss. This mechanism of action sets Zepbound apart from other weight loss drugs as it targets specific hormonal pathways involved in appetite regulation.

Side Effects and safety profile

While Zepbound is generally well-tolerated, it may cause side effects such as nausea, diarrhea, vomiting, constipation, and abdominal discomfort. Injection site reactions, fatigue, allergic reactions, burping, hair loss, and gastroesophageal reflux disease are also possible side effects. It’s important to discuss any concerns or pre-existing medical conditions with a healthcare provider before starting Zepbound.

Dosage and administration

Zepbound is administered through subcutaneous injections once a week. The dosage must be titrated over several weeks to achieve the target dose of 5 mg, 10 mg, or 15 mg once weekly. The maximum recommended dosage is 15 mg once weekly. It’s important to follow the prescribed dosage and administration guidelines a healthcare provider provides.

Cost and availability

The cost of Zepbound may vary depending on factors such as insurance coverage, discounts, and patient assistance programs. It’s advisable to check with insurance providers and explore available resources to determine the cost of Zepbound. Availability may also vary, and individuals should consult with their healthcare provider or pharmacist regarding the availability of Zepbound in their area.

Mounjaro: A closer look

Clinical trials and results

Mounjaro has been extensively studied in clinical trials to evaluate its efficacy in improving blood sugar control in individuals with type 2 diabetes. These trials have shown significant reductions in A1C levels, which indicate improved blood sugar management. Mounjaro has also been associated with weight loss in patients with or without diabetes, making it a potentially valuable option for individuals looking to address both conditions simultaneously.

Mechanism of action

Mounjaro improves blood sugar control by targeting specific pathways involved in glucose regulation. By enhancing insulin sensitivity and reducing glucose production, Mounjaro helps individuals with type 2 diabetes achieve better glycemic control and potentially experience weight loss as a secondary effect.

Side effects and safety profile

As with any medication, Mounjaro has potential side effects that individuals should be aware of. Some common side effects include nausea, diarrhea, vomiting, constipation, and abdominal discomfort. Additionally, Mounjaro has specific warnings regarding the risk of thyroid cancer and pancreatitis and the importance of regular monitoring. It’s crucial to discuss these potential side effects and safety concerns with a healthcare provider before starting Mounjaro.

Dosage and administration

Mounjaro is administered through subcutaneous injections, typically once weekly. The specific dosage and administration guidelines may vary depending on individual factors and the recommendations provided by a healthcare provider. It’s important to follow the prescribed regimen and consult a healthcare provider for personalized guidance.

Cost and availability

The cost of Mounjaro may vary depending on factors such as insurance coverage, discounts, and patient assistance programs. It’s advisable to check with insurance providers and explore available resources to determine the cost of Mounjaro. Availability may also vary, and individuals should consult with their healthcare provider or pharmacist regarding the availability of Mounjaro in their area.

Choosing the right weight loss drug

When faced with the decision of choosing between Zepbound and Mounjaro, individuals should consider several factors. These factors include their specific weight loss goals, existing medical conditions, medication interactions, and personal preferences. Consulting with a healthcare provider is crucial in determining the most suitable weight loss drug based on individual needs and circumstances. By considering these factors and seeking professional guidance, individuals can make an informed decision about the weight loss drug that aligns with their goals and overall well-being

Sources

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Data Security

Trusted and certified to keep your data safe.

Learn moreNow Patient Data SecurityNow Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient dashboard

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers